Skip to main content
SpringerLink
Log in
Book cover

Molecular Diagnostics in Dermatology and Dermatopathology pp 191–202Cite as

Molecular Determination of Tissue Margins, Clonal Origin, and Histogenesis of Skin Cancers

  • Chapter
  • First Online:

Part of the book series: Current Clinical Pathology ((CCPATH))

Abstract

Technologies are being increasingly employed to identify the biological pathways, genes, and ­proteins involved in disease pathogenesis and progression. These investigations have uncovered diagnostic and prognostic biomarkers for a variety of cutaneous tumors. Molecular testing may have a role in the evaluation of tissue margins, clonal origin, and histogenesis of skin cancers.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Dakubo GD, Jakupciak JP, Birch-Machin MA, et al. Clinical implications and utility of field cancerization. Cancer Cell Int. 2007;7:2.

    Article  PubMed  Google Scholar 

  2. Bastian BC, Kashani-Sabet M, Hamm H, et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res. 2000;60:1968–73.

    PubMed  CAS  Google Scholar 

  3. North JP, Kageshita T, Pinkel D, et al. Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma. J Invest Dermatol. 2008;128:2024–30.

    Article  PubMed  CAS  Google Scholar 

  4. Hinshaw M. Use of genetic tools to control tumor margins in melanoma. Arch Dermatol. 2009;145:475–7.

    Article  PubMed  Google Scholar 

  5. Takata M, Murata H, Saida T. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma. Pigment Cell Melanoma Res. 2010;23:64–71.

    Article  PubMed  CAS  Google Scholar 

  6. Takata M, Saida T. Early cancers of the skin: clinical, histopathological, and molecular characteristics. Int J Clin Oncol. 2005;10:391–7.

    Article  PubMed  Google Scholar 

  7. Whalen J, Leone D. Mohs micrographic surgery for the treatment of malignant melanoma. Clin Dermatol. 2009;27:597–602.

    Article  PubMed  Google Scholar 

  8. Griego RD, Zitelli JA. Mohs micrographic surgery using HMB-45 for a recurrent acral melanoma. Dermatol Surg. 1998;24:1003–6.

    Article  PubMed  CAS  Google Scholar 

  9. Pashaei S, Li L, Zhang H, Spencer HJ, et al. Concordant loss of heterozygosity of DNA repair gene, hOGG1, in melanoma in situ and atypical melanocytic hyperplasia. J Cutan Pathol. 2008;35:525–31.

    Article  PubMed  Google Scholar 

  10. Peris K, Keller G, Chimenti S, et al. Microsatellite instability and loss of heterozygosity in melanoma. J Invest Dermatol. 1995;105:625–8.

    Article  PubMed  CAS  Google Scholar 

  11. Funk JO, Schiller PI, Barrett MT, et al. p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma. J Cutan Pathol. 1998;25:291–6.

    Article  PubMed  CAS  Google Scholar 

  12. Quinn AG, Healy E, Rehman I, et al. Microsatellite instability in human non-melanoma and melanoma skin cancer. J Invest Dermatol. 1995;104:309–12.

    Article  PubMed  CAS  Google Scholar 

  13. Smith AP, Weeraratna AT, Spears JR, et al. SAGE identification and fluorescence imaging analysis of genes and transcripts in melanomas and precursor lesions. Cancer Biol Ther. 2004;3:104–9.

    Article  PubMed  CAS  Google Scholar 

  14. Smith AP, Hoek K, Becker D. Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas. Cancer Biol Ther. 2005;4:1018–29.

    Article  PubMed  CAS  Google Scholar 

  15. Hubbard K, Steinberg ML, Hill H, Orlow I. Mitochondrial DNA deletions in skin from melanoma patients. Ethn Dis. 2008;18 Suppl 2:S2-38–43.

    Google Scholar 

  16. Eshaghian A, Vleugels RA, Canter JA, et al. Mitochondrial DNA deletions serve as biomarkers of aging in the skin, but are typically absent in nonmelanoma skin cancers. J Invest Dermatol. 2006;126:336–44.

    Article  PubMed  CAS  Google Scholar 

  17. Steinberg ML, Hubbard K, Utti C, et al. Patterns of persistent DNA damage associated with sun exposure and the glutathione S-transferase M1 genotype in melanoma patients. Photochem Photobiol. 2009;85:379–86.

    Article  PubMed  CAS  Google Scholar 

  18. Brozyna A, Zbytek B, Granese J, et al. Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma. Exp Rev Dermatol. 2007;2:451–69.

    Article  CAS  Google Scholar 

  19. Greinert R. Skin cancer: new markers for better prevention. Pathobiology. 2009;76:64–81.

    Article  PubMed  Google Scholar 

  20. Fabricius EM, Bezeluk A, Kruse-Boitschenko U, et al. Clinical significance of telomerase activity in basal cell carcinomas and in tumour-free surgical margins. Int J Oncol. 2003;23:1389–99.

    PubMed  CAS  Google Scholar 

  21. Bäckvall H, Asplund A, Gustafsson A, et al. Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma. Mutat Res. 2005;571:65–79.

    Article  PubMed  Google Scholar 

  22. Asplund A, Gry Björklund M, Sundquist C, et al. Expression profiling of microdissected cell populations selected from basal cells in normal epidermis and basal cell carcinoma. Br J Dermatol. 2008;158:527–38.

    Article  PubMed  CAS  Google Scholar 

  23. Yu M, Zloty D, Cowan B, et al. Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles. J Invest Dermatol. 2008;128:1797–805.

    Article  PubMed  CAS  Google Scholar 

  24. Howell BG, Solish N, Lu C, et al. Microarray profiles of human basal cell carcinoma: insights into tumor growth and behavior. J Dermatol Sci. 2005;39:39–51.

    Article  PubMed  CAS  Google Scholar 

  25. Bonifas JM, Pennypacker S, Chuang PT, et al. Activation of expression of hedgehog target genes in basal cell carcinomas. J Invest Dermatol. 2001;116:739–42.

    Article  PubMed  CAS  Google Scholar 

  26. O’Driscoll L, McMorrow J, Doolan P, et al. Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays. Mol Cancer. 2006;5:74.

    Article  PubMed  Google Scholar 

  27. Nindl I, Dang C, Forschner T, et al. Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling. Mol Cancer. 2006;5:30.

    Article  PubMed  Google Scholar 

  28. Dang C, Gottschling M, Manning K, et al. Identification of dysregulated genes in cutaneous squamous cell carcinoma. Oncol Rep. 2006;16:513–9.

    PubMed  CAS  Google Scholar 

  29. Serewko MM, Popa C, Dahler AL, et al. Alterations in gene expression and activity during squamous cell carcinoma development. Cancer Res. 2002;62:3759–65.

    PubMed  CAS  Google Scholar 

  30. Edinger JT, Radfar A, Jukic DM. Two cutaneous malignant melanomas at the same anatomic site: a case report with molecular evaluation. J Cutan Pathol. 2009;36 Suppl 1:74–9.

    Article  PubMed  Google Scholar 

  31. Bahrami S, Cheng L, Wang M, et al. Clonal relationships between epidermotropic metastatic melanomas and their primary lesions: a loss of heterozygosity and X-chromosome inactivation-based analysis. Mod Pathol. 2007;20:821–7.

    Article  PubMed  CAS  Google Scholar 

  32. Katona TM, Jones TD, Wang M, et al. Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma. Am J Surg Pathol. 2007;31:1029–37.

    Article  PubMed  Google Scholar 

  33. Savoia P, Fava P, Nardò T, et al. Skin metastases of malignant melanoma: a clinical and prognostic survey. Melanoma Res. 2009;19:321–6.

    Article  PubMed  Google Scholar 

  34. Hussein MR. Skin metastasis: a pathologist’s perspective. J Cutan Pathol. 2010;37:306–7.

    Google Scholar 

  35. Guerriere-Kovach PM, Hunt EL, Patterson JW, et al. Primary melanoma of the skin and cutaneous melanomatous metastases: comparative histologic features and immunophenotypes. Am J Clin Pathol. 2004;122:70–7.

    Article  PubMed  Google Scholar 

  36. Orlow I, Tommasi DV, Bloom B, et al. Evaluation of the clonal origin of multiple primary melanomas using molecular profiling. J Invest Dermatol. 2009;129:1972–82.

    Article  PubMed  CAS  Google Scholar 

  37. Quezado MM, Abati AD, Albuquerque AV, et al. Morphologic diversity in malignant melanoma: the potential use of microdissection and the polymerase chain reaction for diagnosis. Mod Pathol. 1998;11:1010–5.

    PubMed  CAS  Google Scholar 

  38. Blokx WA, Lesterhuis WJ, Andriessen MP. CDKN2A (INK4A-ARF) mutation analysis to distinguish cutaneous melanoma metastasis from a second primary melanoma. Am J Surg Pathol. 2007;31:637–41. Erratum in: Am J Surg Pathol. 2007;31:1137. Lesterhuis, Joost J [corrected to Lesterhuis, W Joost]; Punt, Kees J A [corrected to Punt, Cornelis J A].

    Article  PubMed  Google Scholar 

  39. Balaban GB, Herlyn M, Clark Jr WH, et al. Karyotypic evolution in human malignant melanoma. Cancer Genet Cytogenet. 1986;19:113–22.

    Article  PubMed  CAS  Google Scholar 

  40. Balázs M, Adám Z, Treszl A, et al. Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytometry. 2001;46:222–32.

    Article  PubMed  Google Scholar 

  41. Balázs M, Adám Z, Bégány A, et al. Involvement of chromosome losses in the progression and metastasis formation of a human malignant melanoma. Cancer Genet Cytogenet. 1999;109:114–8.

    Article  PubMed  Google Scholar 

  42. Morita R, Fujimoto A, Hatta N, et al. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression. J Invest Dermatol. 1998;111:919–24.

    Article  PubMed  CAS  Google Scholar 

  43. Torres-Cabala CA, Wang WL, Trent J, et al. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Mod Pathol. 2009;22:1446–56.

    Article  PubMed  CAS  Google Scholar 

  44. Begg CB, Eng KH, Hummer AJ. Statistical tests for clonality. Biometrics. 2007;63:522–30.

    Article  PubMed  Google Scholar 

  45. Kabumoto T, Fujiwara H, Kariya N, et al. Skin metastasis of dermatofibrosarcoma protuberans with distinct morphological features, confirmed by COL1A1-PDGFB fusion gene analysis. J Am Acad Dermatol. 2009;61:130–2.

    Article  PubMed  CAS  Google Scholar 

  46. Nagy J, Fehér LZ, Sonkodi I, et al. A second field metachronous Merkel cell carcinoma of the lip and the palatine tonsil confirmed by microarray-based comparative genomic hybridisation. Virchows Arch. 2005;446:278–86.

    Article  PubMed  Google Scholar 

  47. Schrama D, Thiemann A, Houben R, et al. Distinction of 2 different primary Merkel cell carcinomas in 1 patient by Merkel cell polyomavirus genome analysis. Arch Dermatol. 2010;146:687–9.

    Article  PubMed  CAS  Google Scholar 

  48. Hafner C, Hartmann A, Knuechel R, et al. Molecular genetic analysis excludes implantation metastasis of basal cell carcinomas. Arch Pathol Lab Med. 2003;127:1221–4.

    PubMed  Google Scholar 

  49. Blokx WA, Ruiter DJ, Verdijk MA, et al. INK4-ARF and p53 mutations in metastatic cutaneous squamous cell carcinoma: case report and archival study on the use of Ink4a-ARF and p53 mutation analysis in identification of the corresponding primary tumor. Am J Surg Pathol. 2005;29:125–30.

    Article  PubMed  Google Scholar 

  50. Nakamura H, Hirota S, Adachi S, et al. Clonal nature of seborrheic keratosis demonstrated by using the polymorphism of the human androgen receptor locus as a marker. J Invest Dermatol. 2001;116:506–10.

    Article  PubMed  CAS  Google Scholar 

  51. Hui P, Glusac EJ, Sinard JH, et al. Clonal analysis of cutaneous fibrous histiocytoma (dermatofibroma). J Cutan Pathol. 2002;29:385–9.

    Article  PubMed  Google Scholar 

  52. Indsto JO, Cachia AR, Kefford RF, et al. X inactivation, DNA deletion, and microsatellite instability in common acquired melanocytic nevi. Clin Cancer Res. 2001;7:4054–9.

    PubMed  CAS  Google Scholar 

  53. Maitra A, Gazdar AF, Moore TO, et al. Loss of heterozygosity analysis of cutaneous melanoma and benign melanocytic nevi: laser capture microdissection demonstrates clonal genetic changes in acquired nevocellular nevi. Hum Pathol. 2002;33:191–7.

    Article  PubMed  CAS  Google Scholar 

  54. Harada M, Suzuki M, Ikeda T, et al. Clonality in nevocellular nevus and melanoma: an expression-based clonality analysis at the X-linked genes by polymerase chain reaction. J Invest Dermatol. 1997;109:656–60.

    Article  PubMed  CAS  Google Scholar 

  55. Robinson WA, Lemon M, Elefanty A, et al. Human acquired naevi are clonal. Melanoma Res. 1998;8:499–503.

    Article  PubMed  CAS  Google Scholar 

  56. Heitzer E, Quehenberger F, Wolf P. Polyclonality of multiple sporadic basal cell carcinomas. J Invest Dermatol. 2009;129:1586–9.

    Article  PubMed  CAS  Google Scholar 

  57. Rolz-Cruz G, Kim CC. Tumor invasion of the skin. Dermatol Clin. 2008;26:89–102. viii.

    PubMed  CAS  Google Scholar 

  58. Nashan D, Müller ML, Braun-Falco M, et al. Cutaneous metastases of visceral tumours: a review. J Cancer Res Clin Oncol. 2009;135:1–14.

    Article  PubMed  CAS  Google Scholar 

  59. Sariya D, Ruth K, Adams-McDonnell R, et al. Clinicopathologic correlation of cutaneous metastases: experience from a cancer center. Arch Dermatol. 2007;143:613–20.

    Article  PubMed  Google Scholar 

  60. Bender RA, Erlander MG. Molecular classification of unknown primary cancer. Semin Oncol. 2009;36:38–43.

    Article  PubMed  CAS  Google Scholar 

  61. Ma XJ, Patel R, Wang X, et al. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay. Arch Pathol Lab Med. 2006;130:465–73.

    PubMed  CAS  Google Scholar 

  62. Moyano S, Aguilera P, Petit A, et al. Alveolar soft part sarcoma presenting with cutaneous metastases: report of a case with immunohistochemical and molecular characterization. J Am Acad Dermatol. 2009;61:117–20.

    Article  PubMed  Google Scholar 

  63. Wang E, Panelli MC, Zavaglia K, et al. Melanoma-restricted genes. J Transl Med. 2004;2:34.

    Article  PubMed  Google Scholar 

  64. Bridgewater J, van Laar R, Floore A, et al. Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary. Br J Cancer. 2008;98:1425–30.

    Article  PubMed  CAS  Google Scholar 

  65. Horlings HM, van Laar RK, Kerst JM, et al. Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary. J Clin Oncol. 2008;26:4435–41.

    Article  PubMed  CAS  Google Scholar 

  66. Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26:462–9.

    Article  PubMed  CAS  Google Scholar 

  67. Missero C, D’Errico M, Dotto GP, et al. The molecular basis of skin carcinogenesis. In: Coleman WB, Tsongalis GJ, editors. The molecular basis of human cancer. Totowa: Humana Press; 2002. p. 407–25.

    Google Scholar 

  68. Bolshakov S, Walker CM, Strom SS, et al. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin Cancer Res. 2003;9:228–34.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Dermatopathology, Department of Dermatology, University of Connecticut Health Center, 21 South Rd., Farmington, CT, 06030, USA

    Michael J. Murphy

Authors
  1. Michael J. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J. Murphy .

Editor information

Editors and Affiliations

  1. Health Center, Dept. Dermatology, University of Connecticut, Farmington Ave. 263, Farmington, 06030, Connecticut, USA

    Michael J. Murphy

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Murphy, M.J. (2011). Molecular Determination of Tissue Margins, Clonal Origin, and Histogenesis of Skin Cancers. In: Murphy, M. (eds) Molecular Diagnostics in Dermatology and Dermatopathology. Current Clinical Pathology. Humana Press. https://doi.org/10.1007/978-1-60761-171-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-171-4_9

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-170-7

  • Online ISBN: 978-1-60761-171-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation